Yes. Hi, sir. Congratulations on a good set of numbers. Thank you for taking my question. I just have a few questions. First one on the pharma intermediate segment. The innovator in their conference call had mentioned that they are looking to add other sources for their product, other sources of supply for their product. So just wanted to know how do we make sure that your wallet share in the supply of your intermediates remains intact for that player?
Right, got it. So not news articles, but they are mentioned in that we are looking on for the other sources of product.